Cargando…
Randomized controlled trial of clopidogrel to prevent primary arteriovenous fistula failure in hemodialysis patients
The optimal vascular access for chronic maintenance hemodialysis is the arteriovenous fistula (AVF). Several studies suggest a role for antiplatelet agents in the prevention of primary AVF failure. A double-blind, randomized trial was conducted to assess the efficacy and safety of clopidogrel in hem...
Autores principales: | Ghorbani, A., Aalamshah, M., Shahbazian, H., Ehsanpour, A., Aref, A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847809/ https://www.ncbi.nlm.nih.gov/pubmed/20368925 http://dx.doi.org/10.4103/0971-4065.53323 |
Ejemplares similares
-
Ticlopidine to prevent primary arteriovenous fistula failure in hemodialysis patients; a randomized controlled trial
por: Ghorbani, Ali, et al.
Publicado: (2013) -
Outcomes and predictors of failure of arteriovenous fistulae for hemodialysis
por: Venkat Ramanan, Siddharth, et al.
Publicado: (2021) -
Arteriovenous Fistula Recirculation in Hemodialysis
por: Shayanpour, Shokouh, et al.
Publicado: (2015) -
Survival and Prognostic Predictors of Primary Arteriovenous Fistula for Hemodialysis
por: Wongmahisorn, Yuthapong
Publicado: (2019) -
Association of early failure of arteriovenous fistula with mortality in hemodialysis patients
por: Yap, Yit-Sheung, et al.
Publicado: (2021)